Posted by: admin on: October 11, 2011
Background. Neuromuscular blocking agents are occasionally used in mechanically ventilated patients with severe ventilation and oxygenation impairment when sedatives are not effective.[5] Papazian and associates sought to determine whether treatment with a neuromuscular blocker improved clinical outcomes in patients with early severe acute respiratory distress syndrome (ARDS)
Posted by: admin on: September 12, 2011
Acute Respiratory Distress Syndrome caused by any insult to the lung tissue has a high mortality. This mortality has been found to reduce by the use of neuromuscular blocking agents. Here is a study. Team@CMHF